Show latest about:
Israeli stocks on Wall St
Israeli stocks in Europe
Mergers & acquisitions
Politics, foreign affairs
Start-ups & VC
Israeli stocks in NY
Israel in depth
Teva suffers setback over Copaxone
The US Supreme Court has in effect allowed generic versions of the MS drug from next month.
20 Apr 14 11:26
US attorney: Israeli life sciences IPOs to continue
Robert Grossman sees more Wall Street IPOs despite market weakness.
17 Apr 14 16:21
Teva settles with Pfizer on arthritis treatment
Brand Celebrex has $2.2 billion in US sales in 2013, according to IMS data.
17 Apr 14 16:19
Health Ministry seeks uniform top-up policies
Insurance firms would lose revenue by having to offer identical policies to health funds.
17 Apr 14 10:33
Teva recalls anti-depressant - report
16 Apr 14 18:34
Opko turns Prolor into Israeli R&D, investment arm
16 Apr 14 12:56
Syneron obtains FDA approval for UltraShape
16 Apr 14 12:25
Teva launches generic insomnia treatment in US
16 Apr 14 12:10
Insightec in talks to raise tens of millions of dollars
13 Apr 14 20:15
Hadassah petitions court to keep hospital
13 Apr 14 11:53
If Rose Fostanes played basketball
Reforms in regulations for foreign caregivers are welcome, but don't go far enough.
16 Jan 14 17:54
Private treatment kills public healthcare
If the German Committee validates private healthcare, it will be the last nail in public healthcare's coffin, argues Prof Dani Filc.
Prof. Dani Filc
7 Jan 14 16:36
Reducing the number of polyps that colonoscopies miss
EndoChoice's Israel development center has devised an endoscope with a 330-degree arc.
6 Jan 14 17:28
Neopharm moves into orphan drugs
16 Dec 13 16:03
Merck Serono Israel incubator nurtures early stage projects
15 Dec 13 19:18
Israeli biomed cos bring in US CEOs
4 Dec 13 13:57
2 Dec 13 13:20
Restructuring can help Teva's Copaxone woes
17 Nov 13 18:39
Enabling diabetes patients to sleep soundly
5 Nov 13 13:14
For more results from our archive,